Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Skin cancer is a malignant disease arising from different layers of skin cells (such as melanocytes, basal cells, or squamous cells). Types include melanoma and non-melanoma cancers such as basal cell carcinoma and squamous cell carcinoma. It is often related to prolonged ultraviolet exposure, skin inflammation, or genetic factors. Although some types grow slowly, if not treated promptly, they may invade deeper tissues and metastasize, affecting organ function and threatening life.
The incidence of skin cancer continues to rise worldwide, with Australia, the United States, and Northern European countries having the highest rates. In Asia and Southeast Asia, due to high UV exposure and outdoor labor populations, localized areas such as Thailand and the Philippines are also showing an upward trend. Medical institutions are actively promoting sun protection education and screening programs.
1. Local invasion and organ damage
Some rapidly proliferating skin cancers destroy local tissues. For example, untreated melanoma can deeply infiltrate, cause ulceration and infection, and even affect joints and muscle structures.
2. Severe consequences of distant metastasis
Malignant melanoma can spread via lymphatic or blood circulation to organs such as the lungs, liver, and brain, impairing function and increasing treatment difficulty.
3. Significant decline in quality of life
Skin lesions may cause pain, itching, or bleeding, and when located on exposed areas, they affect appearance and social interactions, leading to psychological stress and emotional distress.
4. Uncertain prognosis and recurrence
Although basal cell carcinoma has a high cure rate, squamous cell carcinoma and melanoma are prone to postoperative recurrence, requiring long-term follow-up. Some patients undergo multiple surgeries and repeated relapses.
Immune reconstruction cell therapy activates the patient’s own immune system to recognize and attack tumors. It enhances T-cell responses to skin lesions, helps clear micrometastases, and is suitable for patients who cannot undergo surgery or need enhanced systemic control. This reduces recurrence risk and extends survival.
During traditional treatments such as surgery, radiotherapy, and chemotherapy, tumor patients often face immune dysfunction, increased infection risk, and slow recovery. To help patients better sustain treatment, improve tolerance, and enhance quality of life, phased immune reconstruction plans tailored to different cycles should be scientifically developed.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion to boost the effectiveness of anti-tumor therapy.
● Mid-term plan: Reduce side effects of traditional treatments, promote recovery, and complete standardized treatment courses.
● Long-term plan: Improve overall immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby enhancing quality of life and prolonging survival.
1. Surgical excision
For early-stage skin cancer, wide local excision is the preferred method to ensure tumor-free margins. For complex sites, flap or graft techniques can be used to achieve both cure and cosmetic repair.
2. Radiotherapy
This is suitable for patients who cannot undergo surgery or those with high recurrence risk, especially in sensitive areas such as the head, neck, or extremities. Radiotherapy can shrink lesions, relieve symptoms, and is often used as an adjuvant therapy.
3. Targeted and systemic immunotherapy
For advanced melanoma, PD-1/PD-L1 inhibitors or BRAF/MEK targeted drugs can be used to enhance immune recognition and suppress tumor growth, improving therapeutic outcomes. They are particularly suitable for patients with multiple lesions or lymphatic metastasis.
Although skin cancer has a high incidence rate, with proper sun protection, early screening, and standardized treatment, most cases can achieve good prognosis. Experts at United Life International Medical Center emphasize that treatment should integrate immune reconstruction, local surgery, and radiotherapy/chemotherapy to achieve individualized management, improve cure rates and quality of life, and prevent recurrence and progression.
